Comparative efficacy of laparoscopic Dor and Nissen fundoplication for refractory gastroesophageal reflux disease. [PDF]
Du X, Dong H, Zhao J, Liu D.
europepmc +1 more source
ABSTRACT Ashwagandha (Withania somnifera) has been recognized for enhancing physical strength, mental well‐being, and overall vitality. Despite its long‐standing use across generations, some clinical reports have noted occasional adverse events. This study compared the safety and tolerability of Ashwagandha Root Extract (ARE) in healthy adults.
Ketan Pakhale +4 more
wiley +1 more source
Evaluating the efficacy and safety of antibody-drug conjugates in non-small cell lung cancer: a systematic review and meta-analysis. [PDF]
Zhang L, Jia H, Niu B.
europepmc +1 more source
[Single needle versus double needle celiac trunk neurolysis in abdominal malignancy pain management: a randomized controlled trial]. [PDF]
Abdelghaffar NA +3 more
europepmc +1 more source
Abstract Study objectives To investigate the use of automated analysis to detect heart rate accelerations (HRAs) to screen for sleep‐disordered breathing (SDB) among patients who use chronotropic medications. Methods Nocturnal polysomnography (NPSG) recordings from 933 participants in the Sleep Heart Health Study were analyzed using an automated method
Nabila Ahmed +11 more
wiley +1 more source
An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triplenegative breast cancer: Erratum. [PDF]
europepmc +1 more source
Diminished Ovarian Reserve: A Narrative Review of Etiologies and Possible Therapeutic Approaches. [PDF]
Lee DY.
europepmc +1 more source
A new nanoparticle‐based biomarker panel is described that can differentiate pancreatic cancer from benign pancreatic disease with a high level of performance. This was enabled by microelectrode array recovery technology that used dielectrophoresis (DEP) to quickly and efficiently recover the nanoparticles from patient plasma samples, followed by on ...
Anna Malakian +23 more
wiley +1 more source
Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study. [PDF]
Wang Z +8 more
europepmc +1 more source

